Catalytic asymmetric transfer hydrogenation of ketones: recent advances by Foubelo, Francisco et al.
1 
 
 
Catalytic asymmetric transfer hydrogenation of ketones: 
Recent advances 
 
Francisco Foubelo, Carmen Nájera and Miguel Yus* 
 
Departamento de Química Orgánica, Facultad de Ciencias, and Centro de Innovación en Química 
Avanzada (ORFEO-CINQA), Universidad de Alicante, Apdo. 99, E-03080 Alicante, Spain 
 
_____________________________________________________________________________________ 
 
Abstract- In this review article we will consider the main processes on asymmetric transfer 
hydrogenation (ATH) of ketones from 2008 up today. The most effective organometallic compounds 
(derived from Ru, Rh, Ir, Fe, Os, Ni, Co, and Re) and chiral ligands (derived from amino alcohols, 
diamines, sulphur- and phosphorous-containing compounds, as well as heterocyclic systems) will be 
shown paying special attention to functionalized substrates, tandem reactions, processes under non-
conventional conditions, supported catalysts, dynamic kinetic resolutions (DKR), the use of water as a 
green solvent, theoretical and experimental studies on reaction mechanisms, enzymatic processes and 
finally applications to the total synthesis of biologically active organic molecules. 
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1. Introduction 
 
The reduction of carbon-oxygen double bonds (carbonyl compounds) is an 
important transformation in synthetic organic chemistry because it is a general 
entry to alcohols.1 Apart of some procedures not generally applied 
(electrochemical, photochemical or biochemical reactions), normally this 
methodology involves the use of molecular hydrogen under catalytic conditions, 
the use of a metal hydride, and transfer hydrogenation (TH). The last method, 
also called hydrogen transfer,2 has several advantages compared to the use of 
hydrogen or hydrides such as (a) simple equipment, (b) low catalyst loading, (c) 
safe manipulation, (d) environmentally friendly solvents, (e) volatile byproducts 
easily removed, and (f) it can be applied to industrial processes.3 Particularly 
significant is the asymmetric version of this reaction, namely the asymmetric 
transfer hydrogenation (ATH),4 for which an asymmetric information in form of a 
chiral ligand is needed, together with a transition metal catalyst, such as those 
derived from ruthenium, rhodium, iridium, iron, and in less extension osmium, 
cobalt, nickel and rhenium. Concerning the general mechanism accepted for the 
TH, exemplified on Scheme 1 by using a secondary alcohol as the hydrogen 
source, it can involve a dihydride intermediate (eq a) or a monohydride one, in 
this second case with two possible variants: the inner sphere without ligand 
assistance (eq b) or the outer sphere with participation of the ligand (eq c) 
(Scheme 1).5 More details on mechanistic aspects will be given later on in the 
corresponding section.  
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Scheme 1. Mechanism for TH: (a) dihydride route; (b) monohydride inner sphere 
mechanism; (c) monohydride outer sphere mechanism.5 
 
In the next part of the article, the most significant information about the ATH of ketones 
from 2008 up today will be given, considering different metal catalysts, ligands and 
reaction conditions, paying special attention to the best enantioselective methodologies 
and their application to synthetic organic chemistry. 
 
2. Reaction scope: Catalysts and chiral ligands 
 
The ATH of alkyl aryl ketones has been performed using different transition metals 
(Ru, Rh, Ir, Fe, Os, Ni, Co, Re) in combination with chiral ligands containing 
coordinating atoms (oxygen, nitrogen, sulphur and phosphorous). 
 
2.1. Ruthenium catalysts 
 
2.1.1.  Aminoalcohols as ligands 
 
Different chiral 1,2-amino alcohols have been used in combination with a Ru catalyst 
for the ATH of prochiral ketones (Table 1). For instance, the ligand 1 was used for the 
enantioselective reduction of several phenones with the p-cymene derived complex 
[RuCl2(p-cymene)]2 (CRu) in KOH as base with good results (Table 1, entry 1).6 The 
isosorbide derivative 2 gave variable data in combination with the benzene complex 
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[RuCl2(benzene)]2 (BRu) and t-BuOK as base (Table 1, entry 2).7 Another isosorbide 
derivative 3 was studied only for acetophenone and pCRu with t-BuOK (Table 1, entry 
3).8  The aminoalcohol 4 was active in the same process with CRu and KOH giving 
variable results (Table 1, entry 4).9 Ethanol was the hydrogen source used in 
combination with the ligand 5 and CRu to get variable results in terms of conversions 
but excellent enantioselectivities (Table 1, entry 5).10 Several ketones were satisfactorily 
reduced with CRu and the aminoalcohol 6, the obtained enantioselectivities being 
explained by calculations (Table 1, entry 6).11 From a series of 1,2-aminoalcohols the 
ligand 7 showed to be the most active in collaboration with CRu working in aqueous 
sodium formate, although variable results were achieved (Table 1, entry 7).12 Based on 
the α-pinene skeleton, several ligands mainly of type 8 (but also their corresponding 
dimers) were prepared and used in the ATH with CRu and KOH as base showed in 
(Table 1, entry 8).13 Finally, Cinchona derivatives were also used as ligands for the 
ATH of aromatic ketones reaching up to 90% ee.14 One special case, that really did not 
use an aminoalcohol, was reported by employing amino acids as ligands and BRu or its 
hexametyl derivative [RuCl2(Me6C6)]2 (HRu) for the ATH of acetophenone, with good 
conversions (up to 95%) but modest enantioselectivities (24-68% ee).15 
 
Table 1. ATH of phenones with ruthenium complexes in the presence of chiral 
aminoalcohols. 
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2.1.2.  Diamines as ligands 
 
Since the pivotal introduction of N-(p-toluenesulfonyl)-1,2-
diphenylethylenediamine (TsDPEN, 9) as chiral ligand for the Ru(II)-catalyzed 
asymmetric transfer hydrogenation of ketones,16 several ligands of this type have 
been reported for that process. In general, two different processes have been 
implemented: either the ligand is used mixed with the Ru catalyst or, in most of 
the cases, the ligand is previously attached to the metal to afford a structurally 
well-defined complex, which is used as the catalyst. For the first approach, the 
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ATH of phenones has been carried out using ligands 1017 and 1118 and CRu as 
the metal complex together with formic acid/triethylamine (TEA) or sodium 
formate/water, respectively, as reduction agents (Table 2, entries 1 and 2, 
respectively). In addition, monotosylated diamine 12 was very effective in terms 
of conversion and enantioselectivity for the ATH of phenones using CRu as 
metallic component (Table 2, entry 3).19  
 
Table 2. ATH of phenones with ruthenium complexes in the presence of chiral 
diamines. 
 
 
Concerning well defined chiral tosyl diamine Ru complexes, used in ATH of 
ketones,20 the complex 13 was the best within a series of different N,N- and arene 
substituted catalysts.21 More recently, several ansa-complexes have been 
developed for the same process, such as compounds 14-18,22-25 which have been 
shown to be active in the ATH of ketones, mainly aromatic derivatives, using the 
formic acid/triethylamine combination as the hydrogen source giving variable 
yields and enantioselectivities. 
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The complex between CRu and TsDPEN (9) was used in the mono reduction of the 
meso epoxydiene 19 to give the alcohol 20 yielding opposite enantiomeric ratio, 
depending on the hydrogen source, a phenomenon never observed before for a similar 
transformation (Scheme 2).26 
 
 
 
Scheme 2. ATH of compound 19 under different reaction conditions. 
 
The diastereomeric ligands 11 and 21 have been used in the CRu-catalyzed ATH 
of phenones using sodium formate in water with variable results. It is remarkable 
that the configuration of the obtained R or S alcohol is independent of the 
stereochemistry of the diamine moiety of the ligand used.27 Other prolinamide 
ligands 2228 and 2329 were the best ones form a series of analogues able to act in 
combination with CRu to perform the ATH of phenones in aqueous sodium 
formate. C2-Symmetric disulfonamide 24 was introduced for the ATH of 
different phenones using isopropanol as the reducing agent, potassium hydroxide 
as the base, and both complexes BRu and CRu as catalysts, in general yields and 
enantioselectivities being excellent.30 Another disulfonamide chiral ligand 25, 
and aryl substituted derivatives were reported to be efficient in the same process, 
but using aqueous sodium formate as reducing agent.31 
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The chiral pool has also been used as a source of chiral ligands in the ATH of ketones. 
For instance, some α-amidothioamide ligands derived from D-glucose of type 2632a or 
2732b have been used with limited success concerning conversion for the ATH of 
acetophenone using sodium isopropanolate in THF as reducing media. However, the 
same process worked nicely when rhodium was used as the metallic component (see 
below). Also derived from (+)-limonene are the amino oximes 28, which have been 
used in combination with different Ru complexes (CRu, BRu, HRu) for the ATH of 
phenones with variable results in terms of conversion and enantioselectivity.33Another 
natural product that has been used to prepare the chiral ligand 29 is (+)-camphor. This 
ligand was employed with CRu and isopropanol and potassium hydroxide as reaction 
medium for the ATH of phenones with modest to poor results.34 
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Natural (+)-limonene was the starting material to prepare Ru complexes of the type 30, 
which were successfully used in the ATH of phenones with the formic 
acid/triethylamine combination. In general, results were better than using complexes 
derived from the same natural product but with different configuration at the 
sterocenters.35 Ruthenacycles of the type 31 have been shown to be effective in the ATH 
of aromatic and heterocyclic ketones using isopropanol and potassium tert-butoxide as 
reduction combination.36 
 
 
 
2.1.3.  Sulphur containing ligands 
 
Few chiral sulfur containing ligands have been involved in the ATH of ketones. Among 
them, the amino thiol 32 was very efficient as its hydrochloride in the HRu-catalyzed 
ATH of phenones using formic acid and triethylamine as the solvent combination. The 
in situ formed complex between the ligand and the Ru moiety was characterized by X-
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ray analysis.37 For the same process, thiourea-derived ligands of the type 33 were 
successfully used, the corresponding intermediate complexes also being characterized 
by the same technique.38 
 
 
 
2.1.4. Phosphorous containing ligands 
 
A series of amino phosphonite derivatives were prepared, generally from natural amino 
acids, and have been used in combination with BRu or mainly CRu for the ATH of 
phenones under isopropanol and basic conditions (sodium or potassium hydroxide). 
Thus, ligands 34,39 3540 and 3641 show a very variable efficiency in the mentioned 
reaction. Not having a diamine-derived structure are the ligands 3742 and 38,43 which 
were reported to be in general efficient for the ATH of different phenones with BRu or 
CRu, respectively, in the presence of isopropanol and sodium hydroxide as the base.  
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Phosphoramidite derivatives 39 and CRu, either reacting in situ or previously prepared, 
catalyzed properly the ATH of acetophenones using isopropanol as a hydrogen source 
and potassium hydroxide as the base, so good conversions but poor enantioselectivities 
were obtained.44 Two phosphine derivatives, namely compounds 4045 and 4146 were 
reported to be active in combination with the ruthenium dichloride-triphenyl phosphine 
complex for the ATH of phenones in the presence of isopropanol and sodium hydroxide 
as base. Actually, the corresponding isolated complexes were directly used in the 
reaction. 
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2.1.5.  Heterocyclic ligands 
 
Ruthenium(II) complexes 4247 and 4348 containing a heterocyclic chiral ligand were 
proven to be excellent catalysts for the ATH of phenones, employing potassium 
isopropoxide in isopropanol as the reducing medium. 
 
4247 (5 mol%)
R = i-Pr, Ph
i-PrOK, i-PrOH
95-96% yield, 56-79% ee
4348 (4 mol%)
i-PrOH, i-PrOH
75-99% conv, 67-99% ee
N
O N
N
H
N
R
Ru
ClPh3P
Cl
NN
H
N
N
O
Ru
ClPh3P
Cl
i-Pr
 
 
From a series of proline derivatives, the ligand 44 was the most efficient in the ATH of 
several phenones using CRu as the metallic component and isopropanol/potassium 
hydroxide as the reaction medium. Results were in general very good and DFT 
calculations could explain the obtained stereochemistry.49 Another triazole-derived 
ligand 45 was the best one from a family of diamine derivatives able to act together 
with a Ru-carbonyl complex as catalyst for the ATH of phenones, isopropanol being the 
hydrogen source under basic conditions. When an aliphatic ketone was reduced, namely 
cyclohexyl methyl ketone, conversion was excellent (93%) but, as expected, 
enantioselectivity was very poor (13% ee).50 
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2.2. Rhodium catalysts 
 
To the best of our knowledge, only one amino alcohol, the ligand 6 (Table 1), was used 
in the ATH of acetophenone under [RhCl2Cp*]2 catalysis (1 mol%) in the presence of 
isopropanol and potassium tert-butoxide, conversion (up to 94%) and enantioselectivity 
(up to 99%) being excellent.11 However, the use of diamines and their derivatives have 
been extensively used in the ATH of phenones. Thus, ligands 927 (Table 2) and 2127 
were employed in combination with the rhodium complex [RhCl2Cp*]2 and sodium 
formate under aqueous conditions to perform the ATH of aromatic ketones with 
variable results (3-68% conv, 22-85% ee). The same reaction conditions, but using the 
ligand 2430 gave excellent results (69-99% yield, 74-99% ee) for the same process. 
Other type of ligands described for this reaction were compounds 46,51 47,52 48,52 4953 
and 5054 with different activity for the ATH of phenones (Table 3). 
 
Table 3. ATH of phenones with rhodium complexes in the presence of chiral 
diamines. 
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Other ligands derived from natural products 2632a and 2732b already described for the 
ruthenium-catalyzed ATH, were also used in connection with the complex [RhCl2Cp*]2 
for the ATH of phenones in general with variable conversions and enantioselectivities 
(12-100% conv, 11-99% ee). Concerning the use of rhodium complexes derived from 
1,2-diamines, compounds 5155 and 5256 have shown to be in general excellent catalysts 
in the ATH of phenones. It is remarkable that in the first case the hydrogenation of an 
aliphatic ketone, namely cyclohexyl methyl ketone worked properly giving 87% conv 
and 87% ee. 
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The complex RhClCp*TsDPEN was very active for the transformation of chromenones 
53 into compounds 54 with formic acid and sodium formate in water. As it is shown, 
both the C=O and the C=C were simultaneously hydrogenated to give the final products 
(Scheme 3).57 
 
 
 
Scheme 3. Compounds 54 prepared by ATH.57 
 
A complex between ligands 3944 and [RhCl2Cp*]2 was also effective in the ATH of 
acetophenone using potassium hydroxide or triethylamine as bases giving modest 
results (20-95% conv, 10-18% ee). The amide or hydroxamic acid derived proline 55 
were used in collaboration with the rhodium complex [RhCl2Cp*]2 to perform mainly 
the ATH of phenones using lithium formate in water as the reaction mixture. 
Conversions and enantioselectivities are generally good.58 The same ligand gave worst 
results when the iridium complex [IrCl2Cp*]2 was used as the organometallic complex. 
Concerning the use of N-heterocyclic carbenes as ligands and a rhodium catalyst, the 
precursor 56 was rather active in the ATH of different phenones under basic conditions 
and with the complex [Rh(cod)Cl]2 as the organometallic component.59 The triazole 
derivative 57 has been reported to be very efficient in the ATH of phenones with 
[RhCl2Cp*]2 as the metallic complex and sodium isopropoxide as the hydrogen 
source.60 
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Rhodium preformed complexes have also been used in these type of reductions. Thus, 
the ATH of several phenones with isopropanol and potassium hydroxide as the 
hydrogen source, under the influence of complex 58, produced the corresponding 
alcohols in good yields and moderate enantioselectivities.61 However, neutral or cationic 
salen rhodium complexes 59 or 60, respectively, gave variable conversions and very 
poor enantioselectivities in the ATH of acetophenone with isopropanol and potassium 
hydroxide as the reaction medium.62 
 
 
 
2.3. Iridium catalysts 
 
From several iridium complexes derived from natural amino acids, the series containing 
a proline moiety 61 is an example of catalysts active in the ATH not only of phenones, 
but also of pinacolone with remarkable results (up to 60% conv, up to 80% ee), 
although with high catalyst loading.63 The tetrahydroisoquinoline derived alcohol 6, 
which worked nicely in these reduction processes with rodium and ruthenium catalysts, 
was also used in combination with the complex [IrCl2Cp*]2 in the ATH of 
acetophenone  under isopropanol and potassium tert-butoxide conditions with moderate 
results (35% conv, 75% ee).11 In addition, similar results were obtained when cationic 
or neutral iridium complexes 6264 and 63,65 were used for the ATH of phenones,  
isopropanol and potassium hydroxide being the reaction medium.  
 
 
 
N-Heterocyclic carbenes, either generated in situ from the ligand and the complex 
[IrCl2Cp*]2 or already prepared, such in the case of complexes 64,66  6567 and 66,68 were 
used in the ATH of phenones with variable results. Similarly, the two sulphur-
containing ligands 6769 and 6870 were efficient in the ATH of aromatic and heterocyclic 
ketones using different iridium(I) complexes as metallic components and isopropanol as 
the hydrogen source. 
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The so-called PN4-ligands 69 and 70 have also been explored in the iridium-catalyzed 
ATH of propiophenone with isopropanol under basic conditions, giving in this case the 
corresponding alcohol with variable results.71 
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2.4. Iron catalysts 
 
Several iron complexes have been reported to be efficient in the ATH of ketones, 
mainly phenones. Thus, when complexes 71,72 7273 and 7374 were used in these 
processes, the corresponding chiral alcohols were produced with variable results. 
Similar results were also obtained with other type of iron derivatives, such as bis-
isonitrile iron complexes 74. The reductions of different cyclic and acyclic alkyl-aryl 
and -heteroaryl ketones were performed in isopropanol under basic conditions.75 
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2.5. Osmium, nickel, cobalt and rhenium catalysts 
 
Other organometallic complexes different than those derived from ruthenium, rhodium, 
iridium and iron have also been used in ATH, although in a lesser extension. Thus, 
osmium complexes of the type 75 derived from a pyridine box ligand have been used in 
the ATH of different phenones in general with excellent conversions and good 
enantioselectivities.76 In the same manner, half-sandwich complexes of osmium(II) with 
natural amino acids 76 have been prepared and used as very efficient catalyst (0.04 
mol%) in the ATH of acetophenone with variable results concerning conversion and 
enantioselectivity.77 In addition, osmium complexes containing the 2-
aminomethylpyridine unit 77 have been shown to be very active in the ATH of aromatic 
ketones with excellent results.78 
 
 
 
Regarding nickel catalysts, to our best knowledge there is only one report on the use of 
a nickel(II) compound in combination with the ligand 78 and employing isopropanol 
under basic conditions as the reducing medium, so different phenones were 
hydrogenated in good yields and enantioselectivities.79 Concerning rhenium, the chiral 
ligand 79 has been shown as the best one, in combination with a rhenium compound, 
from a family of systems of this type in the ATH of several phenones using isopropanol 
and triethylamine as the reaction medium.80 Cobalt has been also involved in these 
reductions. Thus, cobalt nanoparticles, prepared by thermal decomposition of dicobalt 
octacarbonyl, were stabilized by ω-functionalized long-chain carboxylic acids as 80 and 
used as cocatalysts in the ruthenium-catalyzed ATH of phenones.81 
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3. Functionalized substrates 
 
Although several cases of functionalized substrates were treated in the Section 2, in this 
part specific functionalized carbonyl compounds, mainly derived from aromatic and 
heterocyclic ketones, will be considered. α-Alkoxy- and α-thioalkoxy phenones 81 were 
hydrogenated with CRu as catalyst and TsDPEN (9) as chiral ligand in the presence of 
formic acid and triethylamine as the hydrogen source in tetrahydrofuran. Yields and 
enantioselectivities for products 82 are excellent (Scheme 4).82  
 
 
 
Scheme 4. Preparation of functionalized alcohols 82.82 
 
The same catalytic combination was used for the ATH of α-amino phenones 83 under 
similar reaction conditions but using acetonitrile as solvent, so the corresponding chiral 
amino alcohols 84 were obtained (Scheme 5).83 
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Scheme 5. Preparation of amino alcohols 84.83 
 
The ATH of α-fluoro phenones 85 using CRu or [RuCl2(mesitylene)]2 (MRu) and chiral 
diamines 9 or 86 has been performed using sodium formate or the formic 
acid/triethylamine combination giving the expected fluorinated alcohols 87 with up to 
97.5% ee (Scheme 6).84 
 
 
 
Scheme 6. Preparation of β-fluoro alcohols 87.84 
 
Iridium complexes 89 were efficient in the ATH of α-cyano phenones 88 using either 
formic acid (with or without triethylamine) or sodium formate in aqueous methanol as 
the hydrogen source, so the corresponding chiral β-hydroxy nitriles 90 were obtained 
with variable yields and enantioselectivities (Scheme 7).85 
 
 
 
Scheme 7. Preparation of β-hydroxy nitriles 90.85 
 
Several diamines forming in situ iridium complexes were previously tested for the 
transformation of 88 to 90, among them the complex 91 being the most active with 
formic acid in aqueous methanol as reaction medium, to give the expected alcohols in 
45-96% yields and 73-99% ee. The same reaction conditions were applied to the ATH 
of α-nitro phenones 92 to yield the corresponding β-nitro alcohols 93 (Scheme 8).86 
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Scheme 8. Preparation of β-nitro alcohols 93.86 
 
Another type of functionalized ketones are the trichloromethyl derivatives. These 
compounds 94 were submitted to ATH under the ruthenium catalysts 95 with the 
mixture formic acid/triethylamine to yield the corresponding trichloromethyl alcohols 
96 with excellent results. It is remarkable that the reaction worked for both aromatic and 
aliphatic substrates with comparable yields and enantioselectivities (Scheme 9).87  
 
 
 
Scheme 9. Preparation of alcohols 96.87 
 
Unsymmetrical benzyls 97 were hydrogenated with the formic acid/triethylamine 
combination under the catalytic action of complex 95b giving mainly the corresponding 
syn-diols 98 with variable yields but excellent enantio- and diastereoselectivities 
(Scheme 10).88  
 
 
 
Scheme 10. Preparation of diols 98.88 
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Functionalized acetylenic ketones bearing an ester group at the ω-position 99 reacted 
with a mixture of formic acid and triethylamine in a process promoted by the catalyst 
100 to yield the corresponding hydroxy esters 101 in good yields and ee (Scheme 11). 
The same process was also applied to acetylenic diketones, the corresponding anti-diols 
being the reaction products obtained.89 
 
 
 
Scheme 11. Preparation of hydroxy esters 101.89 
 
The complex resulting from the reaction of CRu and TsDPEN (9), generated in situ, 
catalyzed effectively the ATH of the cyclic α-keto amide 102 with formic acid and 
triethylamine yielding the heterocyclic moiety of pantolactam 103 (Scheme 12).90 
 
 
 
Scheme 12. Preparation of lactam 103.90 
 
Aromatic ketones bearing a sulfonamide functionality 104 were the starting materials 
for the complex 95b-catalyzed ATH with formic acid and triethylamine, so the 
corresponding chiral hydroxyl sulfonamides 105 were isolated with excellent levels of 
yields and enantioselectivities (Scheme 13).91 
 
 
 
Scheme 13. Preparation of β-hydroxy sulfonamides 105.91 
 
Finally, the in situ generated α-sulfonyl ketones, starting from α-bromo ketones 106 and 
a sulfinate, were submitted to an ATH with the catalyst 95b and aqueous sodium 
formate yielding the corresponding β-hydroxy sulfones 107 with excellent results 
(Scheme 14).92 
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Scheme 14. Preparation of β-hydroxy sulfones 107.92 
 
4. Tandem reactions 
 
Tandem reactions are of interest in synthetic organic chemistry because complex 
structures can be prepared from more simple precursors, eliminating the need of 
purification steps of the synthetic intermediates, saving on amounts of reagents, labor 
and waste. There are examples in literature of tandem or “multistep one-pot” reactions 
involving an ATH in one of the steps. Thus, reaction of substituted salicylaldehydes 108 
with α-bromo acetophenones 109 under basic conditions gave an acyl benzofuran 
derivative 110, by alkylation followed by Intramolecular aldol condensation, which was 
in situ submitted to an ATH with formic acid and triethylamine catalyzed by the 
rhodium complex 111 to give the corresponding alcohols 112 with excellent results 
(Scheme 15).93 
 
R1 OH
H
O
+
O
Br
R2
Cs2CO3
EtOAc
108 109 110R
1 O O
R2
111 (1 mmol)
HCO2H, Et3N
112
78-96% yield, 80-99% ee
R1
O OH
R2 Rh ClTsN
NHPh
Ph
111  
 
Scheme 15. Preparation of benzofuranyl alcohols 112.93 
 
Another tandem reaction involving an ATH process is the alkylation of acetophenones 
113 with a primary alcohols 11494 in the presence of the complex CRu and the ligand 5 
under basic conditions, in which the alkylated ketone intermediate 115, formed by aldol 
condensation and hydrogenation, suffered ATH giving the corresponding alcohol 116 
with modest yields but good enantioselectivities (Scheme 16).95 
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Scheme 16. Preparation of alcohols 116.95 
 
In the copper-catalyzed cyclization of 2-alkynyl acetophenones 117 in the presence of 
the chiral phosphoric acid 118, an ionic copper intermediate 119 is produced, which was 
in situ hydrogenated by the Hantzsch ester (120) to give the corresponding isochromene 
derivatives 121 with excellent results concerning yields and enantioselectivities 
(Scheme 17).96 
 
R1
O
R2
Cu(OTf)2 (5 mol%)
Ag2CO3 (5 mol%)
118 (10 mol%)
120 (1.4 equiv) R1
O
[Cu]
R2
+
R1
O
R2
121
75-90% yield, 84.8-97.0% ee
117 119
SiPh3
SiPh3
O
O
P
O
OH
N
H
CO2MeMeO2C
118 120  
 
Scheme 17. Preparation of isochromenes 121.96 
 
5. Special reaction conditions 
 
The ATH can be also performed in non-conventional reaction media or under activation 
using different sources of energy. For instance, ultrasound activation in the ATH of 
aromatic and heterocyclic ketones with BRu and (1R,2S)-ephedrine under isopropanol 
and basic conditions got an acceleration of 5-10 times without affecting the 
enantioselectivity (20-98% conv, 8-69% ee).97 
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Ionic liquids, namely N-methylimidazolium hexafluorophosphate [bmim][PF6], have 
been used in the ATH of several phenones with CRu and the chiral ligand 122 in the 
presence of formic acid and triethylamine as the reaction medium giving excellent 
conversions and enantioselectivities.98  
 
 
 
A micromesh gas/liquid reactor has been reported to be very effective for the ATH of 
acetophenone using an aminoindanol pentamethylindium complex as catalyst and 
isopropanol as the hydrogen source, this methodology being interesting for scaling-up 
the process.99 
 
6. Supported catalysts 
 
Some ligands, such as TsDPEN (9) which had shown to be active in ATH were affixed 
on different supports in order to study their behavior.   Among a series of polystyrene 
(PS)-supported ruthenium catalysts used in the ATH of phenones with formic acid and 
triethylamine in dichloromethane, the  TsDPEN derivative 123 was the most effective 
one.100 
In order to work under aqueous conditions a copolymer of polystyrene containing 
phosphonic acid units 124 has been prepared and used in ATH of several phenones, 
formic acid  and triethylamine in water being the reaction medium. Excellent yields and 
enantioselectivities were obtained in all cases.101  
Microspheres made from cross-linked polystyrene bearing diaminosulfonyl 
functionalities and CRu 125 have been shown to be active in the ATH of acetophenone 
with sodium formate under aqueous conditions. Interestingly the polymer was reused 
until four times without losing activity concerning yields and enantioselectivities.102 
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124101 (0.15 mol%)
y/x = 3.66-4.08
HCO2H, Et3N
40-99% yield, 95.1-97.9% ee
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Ru
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125102 (0.1 mol%)
HCO2Na, H2O
58->99% yield, 91-95% ee
z
RuH2N NSO2
Ph
Ph
Cl
PS
123100 (0.6 mol%)
HCO2H, Et3N
26-99% conv, 86-99% ee
 
 
The soluble polymer 126 containing a TsDPEN (9) unit was used in combination with 
BRu for the ATH of aromatic and heterocyclic ketones with formic acid and 
triethylamine as the reaction mixture, so variable conversions but excellent 
enantioselectivities were achieved.103 The three polymer-supported diamine derivatives 
127,104 128105 and 129106 were effective with CRu in the ATH of aromatic, heterocyclic 
and ferrocenyl ketones using in all cases sodium formate under aqueous conditions. 
Results were generally very good in terms of yields and enantioselectivities. 
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The rhodium-supported polymer 130 derived from polyethylene glycol (PEG) was 
efficiently used in the ATH of different phenones with sodium formate in water, giving 
the expected alcohols with excellent results, even after three cycles without losing 
activity.107aA chiral monosulfonyl 1,2-diamine containing a long aliphatic chain was 
successfully used for the rhodium-catalyzed ATH of aromatic ketones.107b 
 
 
 
The vinyl-derived diamine 131 was copolymerized with 1,4-divinylbenzene (DVB) 
inside mesosilica to give a material which after treatment with the complex 
[RhCl2Cp*]2 gave an active catalyst in ATH that was recycled until six times without 
losing any efficiency. Sodium formate in water was the reducing mixture and 
conversions and enantioselectivities were excellent.108  
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One support that has been used extensively for anchoring ruthenium and rhodium 
organometallics is silica. Thus, the ruthenium compound 132109 and the rhodium 
derivative 133110 were very active in the ATH of phenones using aqueous sodium 
formate as hydrogen source. Excellent results were obtained even after ten cycles. The 
catalyst 132 was also immobilized into a magnetic siliceous mesocellular foam material. 
This heterogeneous catalyst afforded high catalytic activity and ee values in the ATH of 
aromatic ketones in aqueous sodium formate. 
 
 
 
When the catalyst 95b was confined into a nanocage with an amphiphilic 
microenviroment the activity of this catalyst in ATH of phenones in aqueous sodium 
formate was enhanced ten times, mainly due to the enhanced diffusion rates of reactants 
during the catalytic process.111  
A combination of [Ir(COD)Cl]2 and 9-amino epi-cinchonine anchored on an external 
surface passivated SBA-15 (134) was satisfactorily used in the ATH of phenones with 
isopropanol and potassium hydroxide as the hydrogen source.112 The same support was 
used to anchor ruthenium catalysts 135, which under the same reaction conditions was 
moderately efficient in the ATH of phenones.113 
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From a family of disulfonamides immobilized on commercially available functionalized 
silica gel, compounds 136 and 137 were the most active in the ATH of acetophenone 
using a rhodium compound and sodium formate in water as the reaction medium.114 
 
 
 
A recoverable organorhodium functionalized polyhedral oligomeric silsesquioxane 138 
exhibited excellent catalytic activity in the ATH of aromatic ketones and analogues in 
aqueous medium with sodium formate as the hydrogen source, the reuse of the catalyst 
having been tested at least in twelve cycles without affecting its activity.115  
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Hybrid core-shell nanospheres containing the unit 139 in the core and poly(methyl 
acrylate) in the shell were prepared by using a sol-gel process. This material was active 
in the ATH of phenones with aqueous sodium formate, and was recycled up to four 
times keeping the same activity.116 
Magnetically recoverable silica-coated iron oxide (SiO2@Fe2O3) nanoparticles were an 
excellent platform for supporting a rhodium or iridium complex, the whole material 140 
being very efficient in the ATH of aromatic ketones with aqueous sodium formate.117 
 
x y
O2S
N
H
Rh
NPh
Ph Cl
139116 (0.002 mol%)
HCO2Na, H2O
27-88% yield, 73->99% ee
O
Si
O OMe
O2S N
NH2
M
R R
Cl
Cp*
140117 (0.2 mol%)
R = R = Ph; R-R = (CH2)4
M = Rh, Ir
77.7->99.9. conv, 74.2-92.5% ee  
 
A mechanistic study on the catalytic activity of the complex 71 in the ATH of 
acetophenone with isopropanol and potassium tert-butoxide concluded that the real 
active species are formed by iron(0) nanoparticles, which support molecules of the 
chiral ligand attached to the surface of the nanoparticles.118 
Denditric fluorinated ligands of the type 141 were used in combination with CRu for the 
ATH of phenones giving excellent results in terms of conversion and enantioselectivity. 
Depending on the dendrimer generation (n = 0-2) the recycling of the catalyst worked 
positively for 5-25 cycles without decreasing in the efficiency.119 
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When chitosan was used for anchoring CRu, the corresponding polymeric complex 142 
was soluble in methanol, and it was active in the ATH of aromatic ketones with 
isopropanol as the hydrogen source under homogeneous conditions.120 
Finally, a chiral rhodium catalyst was immobilized on glass (143) and used in the ATH 
of aromatic ketones with sodium formate in water, giving excellent conversions and 
enantioselectivities.121 
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7. DKR processes 
 
Although a kinetic resolution was applied to substituted flavones,122 since this process 
can give a maximum of 50% yield of each epimer, the most studied reaction of this type 
is the dynamic kinetic resolution (DKR), in which one only enantiomer can be achieved 
starting from a racemic material. 
The CRu-catalyzed DKR of α–acyl substituted tetralones 144 in the presence of 
TsDPEN (9) as chiral ligand, formic acid and triethylamine afforded the corresponding 
hydroxyketones syn-145 with very good results (Scheme 18).123 
 
 
 
Scheme 18. DKR of tetralones 144.123 
 
α-Keto esters 146 were transformed into the chiral substituted lactones using CRu and 
the ligand 147, and the formic acid/triethylamine combination. In this case, the in situ 
spontaneous cyclization of the hydroxyl esters intermediates afforded directly the final 
lactones 148 with very good levels of yields and enantioselectivities, the 
diastereoselection being >20:1 in all cases (Scheme 19).124 
 
CRu (2 mol%)
147 (8 mol%)
HCO2H, Et3N
148
82-94% yield, 78-93% ee
EtO
O Ar
CO2Me
CO2MeO
O
Ar
CO2Me
O
EtO
O
146
NHSO2H2N
Ph
Ph
147  
 
Scheme 19. Preparation of lactones 148 by DKR.124 
 
α-Alkoxy β-keto esters 149 were submitted to the DKR conditions shown above, using 
the catalyst 150, to yield the corresponding syn-diols 151 (Scheme 20).125 
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Scheme 20. DKR of β-keto esters 149.125 
 
In the case of α-hydroxy β-keto phosphonates 152 the application of the same 
methodology achieved the ATH of the keto group yielding the corresponding syn-diol 
derivatives 153 in general with excellent results in terms of yields, enantio- and 
diastereoselectivities (Scheme 21).126 
 
 
 
Scheme 21. Diol derivatives 153 prepared.126 
 
Other β-keto esters bearing a protected amino group at the α-position 154 were 
submitted to DKR combined with an ATH using BRu and the ligand 155 with sodium 
formate in aqueous conditions. The corresponding β-hydroxy α-amino esters anti-156 
were obtained with excellent results. It is remarkable that the reaction also worked for 
compounds having aliphatic substituents at the keto group with similar results than for 
aromatic substrates (Scheme 22).127 
 
 
 
Scheme 22. Functionalized esters 156 prepared.127 
 
The regioisomeric α-hydroxy β-amino esters were obtained using CRu and the 
fluorinated ligand 158 in the presence of the formic acid/triethylamine combination, 
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starting from compounds 157, so the corresponding anti-products 159 were isolated 
with good results (Scheme 23).128 
 
Ar OEt
BocN
O
OH CRu (5 mol%)
158 (5 mol%)
HCO2H, Et3N Ar OEt
BocN
OH
OH
157 159
68-96% yield, 24-98% ee
>20:1 drPh
Ph
NH2
NHSO2C6F5
158  
 
Scheme 23. Functionalized esters 159 prepared.128 
 
For β-keto amides 160, the complex formed by reaction of CRu and the ligand 158 gave 
excellent results in the DKR/ATH giving the corresponding syn-compounds 161 
(Scheme 24).129  
  
 
 
Scheme 24. Preparation of compounds 161.129 
 
Another type of β-keto amides are compounds 162, which by treatment with formic acid 
and triethylamine under catalysis by the complex 163 gave compounds 164 with 
excellent results (Scheme 25).130 
 
 
 
Scheme 25. Preparation of compounds 164.130 
 
The same catalyst 163 was successfully used in the transformation of α-sulfonyl 
aldehydes 165 into the corresponding alcohols 166 in a process that used formic acid 
and triethylamine as the reducing mixture. Interestingly, the reaction worked for both 
aromatic and aliphatic substrates (Scheme 26).131  
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Scheme 26. Preparation of β-hydroxy sulfones 166.131 
 
The DKR of β-keto sulfones via an ATH reaction catalyzed by the complex 163 was 
very efficient with formic acid and triethylamine as the reaction medium, so the starting 
materials 167 gave the anti-products 168 (Scheme 27).132 
 
R1
O
R2
SO2Ph
163 (0.5 mol%)
HCO2H, Et3N
R1
OH
R2
SO2Ph
167 168
87-96% yield, 57->99% ee
51-49->99:1 dr  
 
Scheme 27. β-Hydroxy sulfones 168 prepared.132 
 
8. Water as solvent 
 
Although water was used in many ATH reactions already cited in previous sections, 
especially when sodium formate was used as the hydrogen source,133 in this section 
reactions involving water soluble substrates and/or catalysts, or ionic ligands will be 
considered.134 
Modular amino alcohols 169 were used in the aqueous ATH of acetophenone with CRu 
as the organometallic catalyst and sodium formate as the hydrogen source. Surprisingly, 
a negative effect in conversion was observed with both neutral and ionic surfactants.135 
 
 
 
Chiral water soluble ligands 170,136 171137 and 172138 were used in the ATH of 
phenones with CRu as the organometallic catalyst, using in all cases aqueous sodium 
formate as the reducing component. In general, excellent conversions and 
enantioselectivities were obtained. 
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The monocationic ligand 173 was very efficient in the ATH of phenones using a 
rhodium catalyst and aqueous sodium formate as the reaction mixture.139 Also with the 
same rhodium catalyst, the water soluble triamine ligand 174 was an excellent one for 
the ATH of several aromatic and heterocyclic ketones in water and with sodium formate 
as the reductant.140 
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The ATH of aromatic ketones was carried out satisfactorily in aqueous medium with the 
same rhodium catalyst and the ligand 175 with low catalyst loading and sodium formate 
as the hydrogen source, giving the expected alcohols in general with high yields and 
enantioselectivities.141 
Specially active in aqueous medium is the bifunctionalized catalyst 176 formed from 
flower-like mesoporous silica and the rhodium complex generated from [RhCl2Cp*]2 
and a TsDPEN fragment, and used in the ATH of different phenones with sodium 
formate as the reducing agent.142 
 
 
 
The two polymeric ionic ligands 177143 and 178144 with CRu as metal complex were 
successfully used in the ATH of aromatic ketones in water and with sodium formate as 
the hydrogen source. 
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The polymeric complex 179 was very efficient in the ATH of aromatic ketones in pure 
water and with sodium formate. This amphiphilic block polypeptide based system 
operates under mild conditions giving very high conversions and enantioselectivities, as 
well as high level of recyclability.145 
The use of surfactants for the aqueous ATH has been explored with α-keto esters. Thus, 
dodecyltrimethylammonium bromide (DTAB) showed to be one of the most efficient 
promoters for the CRu-catalyzed ATH of α-keto esters in the presence of the ligand 180 
and sodium formate in water.146 The surfactant acceleration can also be achieved using 
an anionic ligand attached to a ruthenium (181) or rhodium (182) complex and 
cetyltrimethylammonium bromide, so the ATH of a series of aromatic and heterocyclic 
ketones worked nicely with sodium formate and water.147 
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An emulsion promoted by tetra-n-butylammonium iodide (TBAI), working in a biphasic 
dichloromethane/water system, was very efficient for the ATH of phenones with the in 
situ generated catalyst from CRu and TsDPEN (9) giving variable yields (51-99%) and 
enantioselectivities (48-98% ee).148 Another application of the emulsion technology was 
efficiently used for the ATH of α-amido β-keto esters through a DKR with BRu and 
(1S,2S)-2-(benzylamino)-1,2-diphenylethanol as ligand and the formic 
acid/triethylamine combination in water.149 Finally, a surface molecularly imprinted 
ruthenium complex catalyst was used efficiently for the ATH of aromatic and 
heterocyclic ketones in water and using sodium formate as reducing agent, so the 
corresponding alcohols were isolated with 57-99% ee values.150 
 
9. Mechanisms and calculations 
 
Different kinetic results were obtained depending on the rhodium complexes used in the 
ATH of ketones. Whereas pseudo-first order dependence on the substrate was observed 
for thioamide ligands, a pseudo-zero order resulted from hydroxamic acid ones,151 and a 
first order dependence was determined for the rhodium anchored to a polymer.152 
A series of complexes obtained from different chiral 1,2-amino alcohols and ruthenium 
compounds of the type [RuCl2(arene)]2 was submitted to the ATH of acetophenones, 
and evaluated using high-throughput experiments. A genetic algorithm was applied to 
this library in order to adjust the parameters of the algorithm for obtaining a maximum 
of the best catalysts within a minimal number of generations.153 
Several techniques, such as kinetic measurements, isotopic effects, IR and NMR 
probing, as well as DFT modeling and X-ray structure analysis, have been used to study 
the mechanism of the ATH of acetophenone with the ruthenium complexes 183154 and 
184155 using sodium formate and isopropanol, respectively, under basic conditions. A 
series of intermediates have been isolated and a complete mechanism was proposed to 
explain the obtained results. 
A series of ruthenium complexes were prepared in situ by reaction of [RuCl2(arene)]2 
and pseudo-dipeptides 185 and used for the ATH of several phenones with isopropanol 
and sodium isopropoxide as the reducing mixture. From the corresponding kinetic 
studies it was concluded that a novel bimetallic outer-sphere-type mechanism operated 
in this process, in which a bifunctional catalyst mediated the hydride transfer.156 
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Computational studies on the use of several complexes of the type 183, but including 
mesitylene as the arene moiety, in ATH have been performed concluding that in 
contrast to gas phase, the mentioned reactions proceeded via two steps in solution: (i) 
enantio-determining hydride transfer, and (ii) proton transfer through the contact ion-
pair intermediate.157 In another previous study, DFT calculations on the ATH of 
acetophenone with the complex 183 and the formic acid/triethylamine combination 
afforded transition state geometries with the hydrogen transfer taking place through the 
standard six-membered cyclic form.158 
DFT calculations on the ATH of acetophenone with the rhodium complex 186 were 
performed in order to study the activity of this complex in comparison with the 
corresponding ruthenium derivative, concluding that the rhodium system gave better 
results in aqueous conditions in terms of enantioselectivity.159 
The same level of theoretical calculations was applied to the ligands 187 and 188 in the 
ATH of acetophenone, in collaboration to [RhCl2Cp*]2 and isopropanol/sodium 
isopropoxide as the reaction mixture. It was found that three factors operate influencing 
the stereoselectivity: (i) the energy difference between the metal-ligand binding modes, 
(ii) the energy difference between the intermediate hydrogenated catalyst, and (iii) the 
existence of a stabilizing CH-π interaction between the Cp* ligand of the catalyst and 
the phenyl moiety of the substrate.160 
 
 
 
On the basis of a kinetic study a mechanism of activation of the complex 189 (of the 
type 73) was proposed for the ATH of acetophenone in basic isopropanol. The 
intermediates were characterized by multinuclear NMR and high-resolution mass 
spectrometry.161 
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10. Enzymatic reactions 
 
An efficient methodology for the ATH of ketones in aqueous isopropanol was achieved 
with E. coli biocatalysts expressing phenylacetaldehyde reductase from Rhodococcus 
sp. ST-10 and alcohol dehydrogenase from Leifsonia s.p. S749.162  
The catalytic activity of artificial metalloenzymes 190 and 191 derived from bovine β-
lactoglobuline for the ATH of aromatic ketones using sodium formate in water was 
reported. It depends not only on the metal (ruthenium or rhodium) but also on the 
chelating activity and the length of the lipidic chain. The rhodium cofactor derived from 
palmitic acid showed to be the most active in terms of enantioselectivity.163 
 
 
 
11. Applications to total synthesis 
 
In former sections several examples of the application of ATH methodology to the 
synthesis of different functionalities has been described. Here we focus our attention to 
the application of this technology to the total synthesis of interesting organic molecules, 
also at the industrial scale.164  
(R)-(-)-Tembamide (195) and (R)-(-)-aegeline (196), α- and β-adrenergic blockers and 
agonists in the treatment of cardiovascular diseases, were efficiently produced by ATH 
of the corresponding ketones 192 and 193, respectively, with a monosulfonamide 
rhodium complex resulting from the combination of CRu and chiral ligand 194, using 
isopropanol as the reducing reagent, and potassium hydroxide as the base. Reductions 
took place in high yields in a total enantioselective fashion (Scheme 28).165 
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Scheme 28. Synthesis of (-)-tembamide (195) and (-)-aegeline (196).165 
 
An ATH of the keto ester 197 was used in collaboration with chiral  ruthenium catalyst 
198 in basic isopropanol to install the sterocenter at the C-6 position in one step of the 
total synthesis of (+)-centrolobine (200). The corresponding hydroxyl ester 199 was 
obtained in excellent yield and good enantioselectivity (Scheme 29).166 
 
 
 
Scheme 29. Synthesis of (+)-centrolobine (200).166 
 
A similar strategy was used by the same research group in the total synthesis of 
diospongins B (203) and A (204) (the first one being a potent agent against 
osteoporosis) to generate the alcohol functionality at the C-4 position, starting from the 
tetrahydropyran-4H-2-one 201. In this case, the ATH was totally stereoselective, 
leading to tetrahydropyran-4-ol 202 in high yield (Scheme 30).167 
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Scheme 30. Synthesis of diospongins B (203) and A (204).167 
 
The key step in one asymmetric synthesis of antidepressant (S)-duloxetine (207) was the 
formation of the stereocenter bearing the alcohol functionality by ATH with CRu as 
catalyst and TsDPEN (9) as chiral ligand in the presence of formic acid and 
triethylamine as the hydrogen source in methanol. The process took place in high 
chemical yield and good enantioselectivity to transform ketone 205 into alcohol 206 
(Scheme 31).168  
 
 
 
Scheme 31. Synthesis of (S)-duloxetine (207).168 
 
A highly enantioselective synthesis of 1,3-aminoalcohols 211 and 213 was achieved 
also through an ATH of the ketones 208 and 209, respectively, using ruthenium and 
rhodium catalysts in the presence of chiral amino acid based ligands. Optimal results for 
alcohol 211, precursor of (S)-duloxetine (207), were found when CRu was combined 
with ligand 210. In the case of alcohol 213, which is the precursor of antidepressant (R)-
fluoxetine (214), the highest yield and enantioselectivity were found with the 
combination of [RhCp*Cl2]2 and chiral ligand 212 (Scheme 32).169 
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Scheme 32. Synthesis of (R)-fluoxetine (214).169 
 
A rhodium-catalyzed ATH of aryl bromomethyl ketone 215 with sodium formate in 
polyethylene glycol and water as the reaction medium, in the presence of polymer-
supported diamine derivative 127, allowed the enantioselective formation of 
bromohydrine 216,  a direct precursor after four steps of the β2-adrenoreceptor (R)-
salmeterol (217) (Scheme 33).170 
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Scheme 33. Synthesis of (R)-salmeterol (217).170 
 
A ruthenium catalyzed ATH with complex 198 in isopropanol was a key step in the 
synthesis of the potent histone deacetylase inhibitor FK228 (220). Importantly, the 
reduction of aliphatic ketone 218 with this combination led to propargylic alcohol 219 
in good yield and 98% ee. Another key setp in the synthesis of target molecule 220 was 
the formation of the lactone ring under Mitsunobu reaction conditions with inversion of 
the configuration at the carbon atom bearing the alcohol functionality (Scheme 34).171 
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Scheme 34. Synthesis of histone deacetylase inhibitor FK228 (220).171 
 
The only stereocentre present in the anti Alzheimer drug Ladostigol (TV3326, 223) was 
generated by a ruthenium-catalyzed ATH with the CRu-TsDPEN (9) combination of the 
ketone 221 with aqueous sodium formate. The final transformation of the generated 
alcohol 222 (obtained in quantitative yield as a single enantiomer) was performed by a 
SN2 reaction of the corresponding mesylate with propargylamine (Scheme 35).172 
 
 
 
Scheme 35. Synthesis of ladostigol (TV3326, 223).172 
 
Tenofovir (227), an antiviral and immunobiologically active compound, and its 
analogues were also synthesized taking advantage of the ATH to create the stereocentre 
in the molecule using a ruthenium catalyst and sodium formate as the hydrogen source. 
In this case the metallic source was the complex BRu and the chiral ligand the 
pyrrolidinic aminoalcohol 225. The reduction of ketone derivative 224 under the 
reaction conditions shown on Scheme 36 produced compound 226 in reasonable yield 
and good enantioselectivity.173 
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Scheme 36. Synthesis of tenofovir (227).173 
 
Finally a ruthenium catalyst 198 was successfully used for the formation of the 
stereocentre of eslicarbazepine acetate (230) by an ATH of the ketone precursor 228 
(through alcohol 229), using formic acid as a source of hydrogen. It has surprisingly 
been found that high conversions with good enantiomeric excess were obtained by 
using a weak anionic ion exchange resin in place of triethylamine or other tertiary 
amines as base (Scheme 37).174  
 
 
 
Scheme 37. Synthesis of eslicarbazepine acetate (230).174 
 
Other useful applications of the ATH include the total synthesis of (S)-panaxjapyne 
A,175 (+)-yashabushitriol,176 wortmannilactone C,177 (+)-aglaiastatin and (-)-aglaroxin 
C,178 (-)-goniotrionin,179 and huperzin-Q.180 
 
Conclusions 
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As a general conclusion, the most commonly used organometallic complexes uses as 
catalysts in ATH are ruthenium derivatives, namely CRu. Concerning chiral ligands, 
1,2-diamine derivatives are the most versatile ones, among them TsDPEN being the 
most useful. In general, the ATH of ketones works properly only for aromatic and 
heterocyclic ketones, the application to aliphatic ketones being very restricted and 
working with low results in terms of yields and enantioselectivities. Recently, the use of 
supported catalysts and ligands allows the easy recycling of the catalyst and the 
possibility of using this technology for industrial processes. The outstanding 
development of the ATH in the last few years predicts promising findings in the next 
future in the field of synthetic organic chemistry, namely in asymmetric catalysis. 
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